Reuters: Health News: Celsion's liver cancer therapy fails to meet late-stage trial goal

Celsion's liver cancer therapy fails to meet late-stage trial goal

(Reuters) - Celsion Corp said a late-stage study of its experimental liver cancer treatment ThermoDox did not meet the main goal of increasing patient...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/0H1RXeK84BQ/us-celsion-study-thermodox-idUSBRE90U0MI20130131